Showing results (181-190 of 195) with videos related to
Sort By:
Pageof 20
Journal of the Formosan Medical Association = Taiwan Yi Zhi|February 7, 2007
Detection of human metapneumovirus in hospitalized children with acute respiratory tract infection using real-time RT-PCR in a hospital in northern TaiwanPei-Chun Chan, Chung-Yi Wang, Ping-Sheng Wu, et al.The Lancet. Gastroenterology & Hepatology|October 6, 2023
Safety and efficacy of once-weekly efruxifermin versus placebo in non-alcoholic steatohepatitis (HARMONY): a multicentre, randomised, double-blind, placebo-controlled, phase 2b trialStephen A Harrison, Juan P Frias, Guy Neff, et al.Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi|January 23, 2023
Outbreak investigation in a COVID-19 designated hospital: The combination of phylogenetic analysis and field epidemiology study suggesting airborne transmissionYi-Chia Huang, Hsiao-Chen Tu, Han-Yueh Kuo, et al.Emerging Infectious Diseases|October 25, 2012
Community outbreak of adenovirus, Taiwan, 2011Tsung-Pei Tsou, Boon-Fatt Tan, Hsin-Yu Chang, et al.Zhongguo Yi Xue Ke Xue Yuan Xue Bao. Acta Academiae Medicinae Sinicae|July 5, 2023
[Genetic Subtypes and Pretreatment Drug Resistance in the Newly Reported Human Immunodeficiency Virus-Infected Men Aged≥50 Years Old in Guangxi]Ning-Ye Fang, Wen-Cui Wei, Jian-Jun Li, et al.Emerging Infectious Diseases|March 14, 2023
Emergence and Persistent Dominance of SARS-CoV-2 Omicron BA.2.3.7 Variant, TaiwanPei-Lan Shao, Hsiao-Chen Tu, Yu-Nong Gong, et al.Oncogene|December 14, 2019
Correction: Distinct co-acquired alterations and genomic evolution during TKI treatment in non-small-cell lung cancer patients with or without acquired T790M mutationYing Jin, Hua Bao, Xiuning Le, et al.Oncogene|November 23, 2019
Distinct co-acquired alterations and genomic evolution during TKI treatment in non-small-cell lung cancer patients with or without acquired T790M mutationYing Jin, Hua Bao, Xiuning Le, et al.International Journal of Antimicrobial Agents|June 24, 2021
In-vitro activity of cefiderocol, cefepime/zidebactam, cefepime/enmetazobactam, omadacycline, eravacycline and other comparative agents against carbapenem-nonsusceptible Enterobacterales: results from the Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART) in 2017-2020Yu-Lin Lee, Wen-Chien Ko, Wen-Sen Lee, et al.Journal of Global Antimicrobial Resistance|July 21, 2021
National surveillance of antimicrobial susceptibilities to dalbavancin, telavancin, tedizolid, eravacycline, omadacycline and other comparator antibiotics and serotype distribution of invasive Streptococcus pneumoniae isolates in adults: results from the Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART) programme in 2017-2020Ying-Chun Chien, Yu-Lin Lee, Po-Yu Liu, et al.Pageof 20